Novozymes is a world leading biotechnology company with state-of-the-art expertise in microbiology, biotechnology and gene technology. We spend 11-13% of sales on research & development and 15% of our employees work in R&D.
Our biotechnology platform is based on the company's core competences. These enable us to find, develop or refine enzymes and microorganisms that meet our customers' needs and to produce them safely in large quantities.
Our biological production is also state-of-the-art with continued improvements and economies of scale. This means high barriers to entry for new competition.
Novozymes' core competences
|
1. Genetic & biochemical diversity
Culture collection, strain screening, genome sequencing, expression cloning |
4. Pathway engineering
Selection of hosts , genetic engineering, metabolic pathway engineering, homogeneous morphology |
|
2. Protein design
Protein engineering, gene shuffling, molecular modelling, molecular dynamics, directed evolution, high-throughput screening, epitope mapping |
5. Strain development & improvement
Promoter selection, manipulation of operons, yield improvement |
|
3. Protein chemistry
Protein purification, protein sequencing, protein analysis, protein stability, assay development |
6. Large-scale production
Process development, lab fermentation, scale-up, recovery, formulation |
Patents
Novozymes has an extensive patent portfolio with more than 4,200 active patents, patent applications and licensed patents. We continuously and proactively seek partners to license or in-license patents within our interest areas.
See our patent list